1-7 of 7
Yuhua Li, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Improved Safety and Efficacy of a Multi-Target Chimeric Antigen Receptor Modified T Cell Therapy (4SCAR2.0) Against Relapsed or Refractory Lymphomas

Rui Zhang, MSc, Yuhua Li, MD& PhD, Sanfang Tu, MD& PhD, Rui Huang, MD& PhD, Xun Lai, MD, Leping Zhang, MD PhD, Eugene E. Zvonkov, MD PhD, Valeriy G. Savchenko, MD PhD, Nelly G Gabeeva, PhD, Yuchen Liu, MSc, Yuchen Li, MSc, Cheng Jiao, MD PhD, Lan Deng, MD PhD, Xuan Zhou, MD, Hongyu Zhang, MD PhD, Wenli Zhang, MD, Lung-Ji Chang, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 47.
https://doi.org/10.1182/blood-2020-141515
Published: 2020
Journal Articles

CAR2.0 Therapy for the Management of Post-Transplantation Relapse of B-Cell Acute Lymphoblastic Leukemia

Rui Zhang, MSc, Juan Xiao, MD PhD, Zhouyang Liu, MSc, Yuan Sun, MD, Sanfang Tu, MD& PhD, Yuhua Li, MD& PhD, Leping Zhang, MD PhD, Yifei Cheng, MD PhD, Song Xue, MSc, Yongping Zhang, MD PhD, Kai Wang, MD PhD, Bin Wang, MD MSc, Huyong Zheng, MD PhD, Nobuhiro Nishio, MD PhD, Yoshiyuki Takahashi, MD PhD, Jia Feng, MD PhD, Haichan Xu, MD PhD, Yuchen Liu, MSc, Yuchen Li, MSc, Cheng Jiao, MD PhD, Biljana N. Horn, MD, Lung-Ji Chang, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 7.
https://doi.org/10.1182/blood-2020-141531
Published: 2020
Journal Articles

A Novel Chimeric Antigen Receptor T Cells Therapy Strategy That Dual Targeting CD19 and CD123 to Treat Relapsed Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Sanfang Tu, MD PhD, Lan Deng, MD PhD, Rui Huang, MD PhD, Xuan Zhou, MD, Jilong Yang, MD, Weijun Zhou, MD PhD, Meifang Li, MD PhD, Chunyan Yue, MD, Shaojie Wu, MD PhD, Zhenling Guo, Lung-Ji Chang, PhD, Yuhua Li, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4015.
https://doi.org/10.1182/blood-2018-99-118526
Published: 2018
Journal Articles

Therapy of 4s Chimeric Antigen Receptor T Cells Achieves Long-Term Disease-Free Survival with No Severe CRS or Cres in Patients with Relapsed and Refractory Acute Lymphoblastic Leukemia

Sanfang Tu, MD PhD, Rui Huang, MD PhD, Lan Deng, MD PhD, Xuan Zhou, MD, Yanjie He, MD PhD, Weijun Zhou, MD PhD, Jilong Yang, MD, Chunyan Yue, MD, Anqin Wu, Meifang Li, MD PhD, Zhenling Guo, Lung-Ji Chang, PhD, Yuhua Li, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2696.
https://doi.org/10.1182/blood-2018-99-118928
Published: 2018
Journal Articles

Combination of CD19 and CD70 Specific Chimeric Antigen Receptor T Cells Achieves Long-Term Disease-Free Survival in Relapsed and Refractory Primary Central Nervous System Diffuse Large B Cell Lymphoma

Sanfang Tu, MD PhD, Rui Huang, MD PhD, Xuan Zhou, MD, Yanjie He, MD PhD, Zhao Liang, MD PhD, Lei Wang, MD PhD, Lung-Ji Chang, PhD, Yuhua Li, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5389.
https://doi.org/10.1182/blood-2018-99-117694
Published: 2018
Journal Articles

Phase I/II Trial of Multi-Target Chimeric Antigen Receptor Modified T Cells (4SCAR2.0) Against Relapsed or Refractory Lymphomas

Lung-Ji Chang, PhD, Yuhua Li, MD& PhD, Sanfang Tu, MD& PhD, Xun Lai, MD, Rui Huang, MD& PhD, Shih-Ting Tsao, MSc, Yu-Chen Liu, MSc, Rui Zhang, MSc, Lan Deng, MDPhD, Xuan Zhou, MD, Hongyu Zhang, PhD MD, Wenli Zhang, MD, Yuchen Li, MSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 225.
https://doi.org/10.1182/blood-2018-99-114396
Published: 2018
Journal Articles

HIF1A Is a Critical Downstream Mediator for Hemophagocytic Lymphohistiocytosis

Yoshihiro Hayashi, MD PhD, Rui Huang, MD PhD, Xiaomei Yan, Jiachen BU, PhD, Jieyu Wang, MD PhD, Yue Zhang, MD PhD, Yile Zhou, MD, Yuting Tang, MD, Lingyun Wu, MD PhD, Zefeng Xu, MD, Xin Liu, MD PhD, Qianfei Wang, PhD, Jianfeng Zhou, Zhijian Xiao, James P Bridges, PhD, Rebecca A Marsh, Kejian Zhang, MD MBA, Michael B. Jordan, MD, Yuhua Li, MD, Gang Huang, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3565.
https://doi.org/10.1182/blood.V130.Suppl_1.3565.3565
Published: 2017